ANGELA SKOUSEN: Open Payments
NPI 1407441751 · BRISTOW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$450 in 10 payments from 8 companies in 2025. Trend: 2023 $1,706 · 2024 $1,491 · 2025 $450
Food & beverage: $450
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $127 |
| Xeris Pharmaceuticals, Inc. | 1 | $124 |
| ABBVIE INC. | 1 | $77 |
| AstraZeneca Pharmaceuticals LP | 2 | $47 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Astellas Pharma US Inc | 1 | $21 |
| Lilly USA, LLC | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: JARDIANCE, GVOKE HYPOPEN, VRAYLAR, BREZTRI, AIRSUPRA, AUSTEDO XR, Veozah, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
